# Study of Uveitic Macular Edema Treated With Ranibizumab or Steroids

> **NCT00846625** · PHASE2 · WITHDRAWN · sponsor: **University of Utah**

## Conditions studied

- Macular Edema
- Uveitis

## Interventions

- **DRUG:** triamcinolone
- **DRUG:** ranibizumab

## Key facts

- **NCT ID:** NCT00846625
- **Lead sponsor:** University of Utah
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2009-11
- **Primary completion:** 2011-08
- **Final completion:** 2011-08
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Insufficient enrollment (no subjects were enrolled)
- **Last updated:** 2014-12-11

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00846625

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00846625, "Study of Uveitic Macular Edema Treated With Ranibizumab or Steroids". Retrieved via AI Analytics 2026-08-24 from https://api.ai-analytics.org/clinical/NCT00846625. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*